Related Experiment Video
Updated: Aug 5, 2025
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
MiRNA-1976 Regulates the Apoptosis of Dopaminergic Neurons by Targeting the PINK1 Gene
Feng Qiu1, Yue Wu2, Guojin Xie3
1Cerebrovascular Disease Center, Nanjing Brain Hospital Affiliated to Nanjing Medical University, 210029 Nanjing, Jiangsu, China.
Introduction:
Parkinson's disease (PD), which is a neurodegenerative disease, requires urgently needed biomarkers to explore its mechanism. We screened for differences in the expression of microRNAs (miRNAs) and identified miR-1976 as a possible biomarker.
Methods:
Twenty-three patients and 30 controls were included in this study. Dopaminergic neurons from C57/BL mice were cultured. The miRNA expression profiles were analyzed using an miRNA microarray. MiR-1976 was identified as an miRNA that was differentially expressed between PD patients and age-matched controls. Lentiviral vectors were constructed, then apoptosis in dopaminergic neurons was analyzed using MTS (multicellular tumor spheroids) and flow cytometry. Transfection of miR-1976 mimics into MES23.5 cells was performed, and target genes and biological effects were analyzed.
Results:
Overexpression of miR-1976 increased apoptosis and mitochondrial damage in dopaminergic neurons. PINK1 (PINK1-induced kinase 1) was the most common target protein of miR-1976, and silencing of PINK1 caused mitochondrial damage and increased apoptosis of MES23.5 cells.
Conclusions:
MiR-1976 is a newly discovered miRNA that exhibits a high degree of differential expression with respect to the apoptosis of dopaminergic neurons. Given these results, increased expression of miR-1976 may increase the risk of PD by targeting PINK1 and may therefore be a useful biomarker for PD.
Insights
Researchers identified miR-1976 as a potential biomarker for Parkinson's disease (PD). Increased miR-1976 expression in dopaminergic neurons may elevate PD risk by targeting PINK1, suggesting its utility in PD diagnostics.
Area of Science:
- Neuroscience
- Molecular Biology
- Biomarker Discovery
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder lacking sufficient biomarkers.
- MicroRNAs (miRNAs) are crucial in cellular regulation and disease mechanisms.
- Identifying novel biomarkers is essential for understanding PD pathogenesis.
Purpose of the Study:
- To investigate the role of microRNAs in Parkinson's disease.
- To identify potential miRNA biomarkers for PD.
- To elucidate the mechanism of miR-1976 in dopaminergic neuron apoptosis.
Main Methods:
- Analysis of miRNA expression profiles in PD patients and controls.
- Culture and manipulation of dopaminergic neurons (MES23.5 cells).
- Assessment of apoptosis and mitochondrial damage using MTS and flow cytometry.
- Identification of miR-1976 targets using lentiviral vectors and gene silencing.
Main Results:
- MiR-1976 was significantly differentially expressed in PD patients.
- Overexpression of miR-1976 induced apoptosis and mitochondrial damage in dopaminergic neurons.
- PINK1 (PTEN-induced kinase 1) was identified as a direct target of miR-1976, mediating its effects.
Conclusions:
- MiR-1976 is a novel miRNA implicated in dopaminergic neuron apoptosis.
- Increased miR-1976 expression may contribute to PD pathogenesis by targeting PINK1.
- MiR-1976 shows promise as a potential biomarker for Parkinson's disease.
More Related Videos
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
02:23Abnormal Proliferation
01:22MicroRNAs